Results

Total Results: 1,220 records

Showing results for "treatment".

101. Evidence Summary: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-depression-suicide-risk-adults
     June 20, 2023 - Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms … Maternal, fetal, and child outcomes of mental health treatments in women: ameta-analysis of pharmacotherapy … Dialectical behavior therapy as a precursor to PTSD treatment for suicidal and/or self-injuring women … The effect of a therapeutic smartphone application on suicidal ideation in young adults: findings from … Adverse effects of pharmacologic treatments of major depression in older adults.

102. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
     June 09, 2020 - In treatment-seeking populations, opioid agonist therapy and naltrexone were associated with decreased … Retention in substance use treatment was also an outcome for pharmacological therapy. … After 4 to 12 months of treatment, opioid agonist therapy was associated with de- creased risk of relapse … Pharmacological Therapies Opioid Agonist Therapy (Buprenorphine or Methadone) | Four trials of buprenorphine … Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers

103. Final Research Plan: Hepatitis B Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-b-virus-infection-screening
     March 14, 2019 - Interventions KQs 1–3: Screening, including alternative screening strategies (KQ 3) KQs 4–7: Antiviral treatments … Therapies will be classified as: Preferred: Pegylated interferon (adults), nonpegylated interferon … tenofovir alafenamide Nonpreferred: Lamivudine, adefovir, and telbivudine KQs 4–7: Antiviral treatments … not approved by the FDA; combination therapy Comparators KQs 1, 2: No screening KQ 3: … nonpreferred antiviral therapies KQ 7: Effects on intermediate outcome (HBV DNA level, HBeAg status

104. Final Research Plan: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-pregnant-persons
     March 02, 2023 - What are the harms of treatment of syphilis with penicillin during pregnancy to pregnant persons or newborns … time during pregnancy, who are not known to have syphilis infection KQ 3: Studies of penicillin treatment … in nonpregnant persons; studies of penicillin treatment for any condition other than syphilis … syphilis with a nontreponemal and treponemal test (traditional or reverse sequence algorithms) KQ 3: Treatment … (e.g., false-positive and false-negative results, stigma, and psychosocial harms) KQ 3: Harms of treatment

105. Final Research Plan: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-in-pregnancy-screening
     March 02, 2023 - What are the harms of treatment of syphilis with penicillin during pregnancy to pregnant persons or newborns … time during pregnancy, who are not known to have syphilis infection KQ 3: Studies of penicillin treatment … in nonpregnant persons; studies of penicillin treatment for any condition other than syphilis … syphilis with a nontreponemal and treponemal test (traditional or reverse sequence algorithms) KQ 3: Treatment … (e.g., false-positive and false-negative results, stigma, and psychosocial harms) KQ 3: Harms of treatment

106. Final Research Plan: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obstructive-sleep-apnea-in-adults-screening
     March 04, 2021 - How effective is treatment with positive airway pressure (PAP) or mandibular advancement devices (MADs … How effective is treatment with PAP or MADs for improving health outcomes in persons with OSA, including … What are the harms associated with treatment of OSA using PAP or MADs, including for specific subgroups … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … In response to public comments, the USPSTF revised the treatment eligibility criteria to clarify the

107. Final Research Plan: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/latent-tuberculosis-infection-screening
     June 17, 2021 - or who had received no more than a few weeks of treatment. … observed therapy for 6 or 9 months, RIF daily for 4 months, or INH plus RPT weekly by directly observed … therapy for 3 months) compared with placebo, no treatment, delayed treatment, or another eligible treatment … KQs 3, 5: Studies comparing other treatments or combinations (i.e., regimens that are not recommended … KQ 4: False-positive results leading to unnecessary testing or treatment, labeling, stigma, anxiety,

108. Depression and Suicide Risk Screening: Updated Evidence Summary and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
     September 09, 2021 - Efficacy of self-guided internet-based cognitive behavioral therapy in the treatment of depressive symptoms … Maternal, fetal, and child outcomes of mental health treatments in women: a meta-analysis of pharmacotherapy … Dialectical behavior therapy as a precursor to PTSD treatment for suicidal and/or self-injuring women … The effect of a therapeutic smartphone application on suicidal ideation in young adults: findings from … Adverse effects of pharmacologic treatments of major depression in older adults.

109. Recommendation: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chronic-obstructive-pulmonary-disease-screening
     May 10, 2022 - to stop smoking. 12 Pharmacologic therapies (eg, bronchodilators and anti-inflammatory therapies) … and nonpharmacologic therapies (eg, interventions addressing self-management of disease, diet, exercise … (LABAs), long-acting muscarinic antagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

110. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/mggnaKHr496c8QCgHe9-tm
     May 01, 2021 - to stop smoking.12 Pharmacologic therapies (eg, bronchodilators and anti- inflammatory therapies) and … nonpharmacologic therapies (eg, in- terventions addressing self-management of disease, diet, exer- cise … LABAs), long-acting muscarinic an- tagonists (LAMAs), inhaled corticosteroids (ICS), or combination therapy … cardiovascular risk association with LABAs or LAMAs was absent, or even reduced, with prevalent use of inhaled therapy … The USPSTF describes the benefits and harms of pharmacologic and nonpharmacologic COPD treatments in

111. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
     December 21, 2023 - (i.e., what percentage of men initially choose active surveillance or watchful waiting vs. curative treatments … such as surgery, radiation, or ablative therapy)?     … (external beam radiation therapy, proton beam therapy, and brachytherapy) Cryosurgery/high-intensity … focused ultrasonography/other focal ablative therapies Active surveillance ‡ Watchful waiting ‡ … ‡Active surveillance and watchful waiting are typically compared to more active treatments in trials.

112. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
     May 02, 2023 - persons in the isoniazid-only group, and combination therapy was found to be noninferior. … isoniazid and 1.1% for rifampin. 131 Meta-analysis found no statistically significant difference between treatments … It is unclear whether changes in the prevalence of tuberculosis (which has decreased), treatments for … noninferiority, improved adherence, and lower risk of hepatotoxicity for current, CDC-preferred LTBI treatments … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

113. Evidence Summary: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/gestational-diabetes-screening
     August 10, 2021 - For benefits of screening and treatment, comparisons were against no screening or treatment, respectively … Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized … multiple gestations, corticosteroid use 30 d prior to enrollment, gastric bypass surgery, use of fertility treatments … OGCT-positive and 1 abnormal value by Carpenter and Coustan criteria 24-28 wGA Group 1: Diet therapy … : No significant association with SGA, low birth weight, neonatal hypoglycemia requiring IV glucose therapy

114. Recommendation: Genital Herpes Infection: Serologic Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/genital-herpes-serologic-screening
     February 14, 2023 - helpful, and repeat serologic testing may be indicated. 4 In symptomatic pregnant persons, antiviral therapy … Sexually transmitted infections treatment guidelines, 2021: genital herpes. … https://www.cdc.gov/std/treatment-guidelines/herpes.htm 4. … Sexually transmitted infections treatment guidelines, 2021. … https://www.cdc.gov/std/treatment/SexualHistory.htm 16.

115. Recommendation: Gestational Diabetes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-screening
     August 10, 2021 - Treatment and Interventions Initial treatment generally includes moderate physical activity, dietary … Interventions included both dietary and medical therapies. … , treatment was started earlier in pregnant persons who were determined to be at high or higher risk … One trial found no association between treatment of gestational diabetes and impaired fasting glucose … Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

116. Screening for Anxiety in Children and Adolescents: US Preventive Services Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qWZxPBqpffTYVNvGYPkohz
     May 01, 2021 - ) • Individual cognitive behavioral therapy for symptomatic youth who have been exposed to traumatic … Treatment or Interventions Treatment for anxiety disorders can include psychotherapy, phar- macotherapy … limited evidence was available on accuracy of screening questionnaires and effective- ness of anxiety treatments … and pharmaco- therapy and combinations thereof. … One study evaluated homicidal ide- ation but showed no pattern with cognitive behavioral therapy.

117. Final Research Plan: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-obstructive-pulmonary-disease-screening
     October 08, 2020 - What are the adverse effects of COPD treatments in this population? … beta-agonists, anticholinergics, inhaled corticosteroids, CXCR2 antagonists, or combinations of these treatments … ); nonpharmacologic therapy (including case management, behavioral counseling, and exercise therapy) … ; surgical therapies; lung transplant; treatment of acute exacerbations; systemic corticosteroids; phosphodiesterase … , surgical treatment to reduce lung volume, and lung transplantation).

118. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/4GH3or2_-oQ7ChXfjCB2ux
     March 02, 2020 - Antiviral therapy is not generally consid- ered during pregnancy because of the lack of data on the safety … Currently recommended DAA regimens are associated with fewer harms than older interferon-containing therapies … Sus- tained virologic response after antiviral therapy was consistently as- sociated with decreased risk … Direct-acting antiviral regimens are associated with fewer harms than older interferon-containing therapies … for headache and were also lower when compared with rates reported for older interferon- containing therapies

119. Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/DxeDM5ywg2J7SwKmETXfbX
     May 01, 2021 - .4 Mandibular advancement devices (MADs) are an alternative therapy to positive airway pressure for … .15,16 Surgical interventions for OSA are available, but they gen- erally are not considered first-line treatments … pain or discomfort.15,16 In general, the adverse events related to posi- tive airway pressure and MAD therapy … The focus of this recommendation is first-line therapies for OSA. … Surgical therapies are typically reserved for patients who do not respond to first-line therapies or

120. Draft Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/chronic-kidney-disease-screening
     January 19, 2023 - Among adults with CKD stages 1–3, † what are the effects of treatment on clinical outcomes? … Among adults with CKD stages 1–3, † what are the effects of treatment on harms? … whether patients have screen- or non-screen-detected CKD, or whether patients are eligible for evaluated treatments … Sodium-glucose cotransporter-2 inhibitors Glucagon-like peptide-1 agonist Statins Screening tests and treatments … vs. placebo, usual care, or no treatment More intensive vs. less intensive treatment (management of